Account
Insider Insights
14.04.2025
Reflections on the March 2025 EU HTA Webinar 

On 21 March 2025, the European Commission hosted a public webinar to share updates on the implementa...

Read more
Insider Insights
09.04.2025
25 Years of NICE: Reflections and Achievements

Celebrating its 25th anniversary, NICE hosted a conference looking back at its progress and ahead to...

Read more
Insider Insights
07.04.2025
Reforming Health Technology Assessments to Embrace...

The advent of cell and gene therapies (CGTs) represents a paradigm shift in medicine, offering the p...

Read more
Insider Insights
17.10.2024
A closer look at Spain’s new pharmaceutical acce...

Spain is set to implement a comprehensive reform to its law of guarantees and rational use of medici...

Read more
Insider Insights
05.09.2024
NICE’s 1000th Appraisal: Iptacopan for Paroxysma...

The recent appraisal by the National Institute for Health and Care Excellence (NICE) for Iptacopan, ...

Read more
Insider Insights
28.08.2024
NICE rejects first drug proven to slow Alzheimerâ€...

Despite positive outcomes in treating Alzheimer's disease, NICE cites small benefits and high costs ...

Read more
Insider Insights
16.08.2024
Health Technology Evaluation

Key findings from the ABPI's latest report highlight challenges and opportunities in NICE's health t...

Read more
Insider Insights
15.08.2024
Significant update in US drug pricing: Medicare to...

The Biden administration’s recent drug price negotiations under the Inflation Reduction Act re...

Read more
Insider Insights
14.08.2024
Spanish Ministry of Health unveils long-awaited Dr...

The Spanish Ministry of Health's Draft Royal Decree on HTA reshapes assessments, aligning with EU-H...

Read more
Insider Insights
08.08.2024
World’s first CRISPR-based Gene Therapy Exa-cel ...

NICE recommends gene therapy for severe beta-thalassaemia, offering hope for improved quality of lif...

Read more

Stay in the know, subscribe to our newsletter

Be the first to receive exclusive content on the latest from the pharmaceutical and market access sector.